Zoll aligns with Inovise for ECG technology

Justine Varieur Cadet | | Cardiovascular Business | Electrocardiography
Zoll Medical, a manufacturer of resuscitation devices and related software solutions, has entered into a multi-year agreement to license Inovise Medical's Audicor technology.

The Audicor technology analyzes heart sounds to provide more diagnostic capabilities, in addition to the ECG alone, to aid in diagnosing acute and occasionally occult heart failure, according to the Chelmsford, Mass.-based company.

Inovise of Portland, Ore., includes ECG algorithms for improved MI detection and Audicor, which evaluates the performance of the heart by analyzing heart sounds and cardiac timing intervals.

Justine Varieur Cadet

Related Content

FDA clears credit card-sized heart monitor
AI-powered ECG screening a cost-effective way to ID heart failure patients
Eko Health’s AI platform for digital stethoscopes granted new CPT code
FDA grants AI-powered ECG screening tool for aortic stenosis its breakthrough device designation
Homemade electrodes made of putty capture heart data as well as some commercial devices
JACC editor excited by progress during a 'very important moment' for cardiology

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.